IRA A GREENSTEIN

CIK 1228161 · President · last filed 2017-01-19

IRA A GREENSTEIN is a President who has filed 42 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $18.2K of GNE on Jan 19, 2017. Across all open-market trades the lifetime net is +$228.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.95M

Companies

6

Total Filings

42

Lifetime Open-Market Net

$228.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GNE President 100,985 $14.32 $1.45M $0 13 2017-01-19
NeuBase Therapeutics, Inc. (OHRP) Delisted Director 331,051 $8.4K 6 2016-01-26
DSS Director 12 $0.54 $7 $0 7 2015-01-13
IDT President 51,552 $67.88 $3.50M $0 1 2011-04-06
IDT CORP (IDT.C) Delisted President 51,557 $205.3K 7 2011-01-04
DSS, INC. (DMC) Delisted Director 10,000 $15.0K 3 2009-04-20

Recent Filings

42 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-01-19 GNE Tax (F) −3,108 -$18.2K EDGAR
2016-07-20 Grant (A) $0
2016-06-17 GNE Mixed $0 EDGAR
2016-06-17 GNE Mixed $0 EDGAR
2016-01-26 NeuBase Therapeutics, Inc. (OHRP) Delisted Grant (A) $0 EDGAR
2016-01-14 GNE Tax (F) −3,096 -$28.8K EDGAR
2016-01-11 NeuBase Therapeutics, Inc. (OHRP) Delisted Grant (A) $0 EDGAR
2015-08-06 Grant (A) $0
2015-06-15 GNE Mixed $0 EDGAR
2015-03-12 NeuBase Therapeutics, Inc. (OHRP) Delisted Grant (A) $0 EDGAR
Showing 110 of 42
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.